Oversight & Investigations

Subcommittee

Subcommittee on Oversight & Investigations

Responsible for conducting oversight and investigations of any matter related to the jurisdiction of the full committee.

Subcommittees News & Announcements


Chairmen Guthrie and Palmer Announce Oversight & Investigations Subcommittee Hearing Probing the Biden Administration’s Energy and Environment Spending

WASHINGTON, D.C.  – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, and Congressman Gary Palmer (AL-06), Chairman of the Subcommittee on Oversight & Investigations, announced the first hearing of the 119th Congress for the Subcommittee on Oversight & Investigations titled  Examining the Biden Administration’s Energy and Environment Spending Push .  “In its final months, the Biden-Harris Administration handed out billions of dollars in energy and environment grants and loans at an unprecedented pace, exacerbating concerns that appropriate vetting and due diligence reviews may not have occurred for some of these awards,”  said Chairmen Guthrie and Palmer.   “This hearing will provide an opportunity for the Committee to examine this surge in spending and help identify potential misuse of federal funds.”    Subcommittee on Oversight and Investigations hearing titled  Examining the Biden Administration’s Energy and Environment Spending Push .  WHAT: Subcommittee on Oversight and Investigations hearing examining Biden-Harris Administration energy and environment spending. DATE: Wednesday, February 26, 2025     TIME: 10:30 AM ET  LOCATION: 2322 Rayburn House Office Building  This notice is at the direction of the Chairman. The hearing will be open to the public and press and will be livestreamed online at energycommerce.house.gov . If you have any questions concerning this hearing, please contact Calvin Huggins at Calvin.Huggins1@mail.house.gov . If you have any press-related questions, please contact Zach Bannon at Zach.Bannon@mail.house.gov .  ###



Jan 14, 2025
Press Release

Chairman Guthrie Announces 119th Energy and Commerce Republican Subcommittee Assignments

WASHINGTON, D.C.  – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, announced subcommittee membership for the 119 th  Congress. “Today, I am proud to announce the House Committee on Energy and Commerce subcommittee assignments for the 119 th Congress,”   said Chairman Guthrie.   “Energy and Commerce Republicans are ready to hit the ground running, delivering for President Trump’s America First agenda to restore the American Dream.” The Subcommittee Rosters are as follows: Subcommittee on  Communications and Technology: Rep. Richard Hudson (NC-09), Chairman Rep. Rick Allen (GA-12), Vice Chairman Rep. Bob Latta (OH-05) Rep. Gus Bilirakis (FL-12) Rep. Buddy Carter (GA-01) Rep. Neal Dunn (FL-02) Rep. John Joyce (PA-13) Rep. Russ Fulcher (ID-01) Rep. August Pfluger (TX-11) Rep. Kat Cammack (FL-03) Rep. Jay Obernolte (CA-23) Rep. Erin Houchin (IN-09) Rep. Russell Fry (SC-07) Rep. Tom Kean, Jr. (NJ-07)  Rep. Craig Goldman (TX-12) Rep. Julie Fedorchak (ND-AL) Rep. Brett Guthrie (KY-02), Ex-Officio Subcommittee on  Energy: Rep. Bob Latta (OH-05), Chairman Rep. Randy Weber (TX-14), Vice Chairman Rep. Gary Palmer (AL-06) Rep. Rick Allen (GA-12) Rep. Troy Balderson (OH-12) Rep. August Pfluger (TX-11) Rep. Diana Harshbarger (TN-01) Rep. Mariannette Miller-Meeks (IA-01) Rep. John James (MI-10) Rep. Cliff Bentz (OR-02) Rep. Russell Fry (SC-07) Rep. Laurel Lee (FL-15) Rep. Nick Langworthy (NY-23) Rep. Michael Rulli (OH-06) Rep. Gabe Evans (CO-08) Rep. Craig Goldman (TX-12) Rep. Julie Fedorchak (ND-AL) Rep. Brett Guthrie (KY-02), Ex-Officio Subcommittee on  Health: Rep. Buddy Carter (GA-01), Chairman Rep. Neal Dunn (FL-02), Vice Chairman Rep. Morgan Griffith (VA-09) Rep. Gus Bilirakis (FL-12) Rep. Dan Crenshaw (TX-02) Rep. John Joyce (PA-13) Rep. Troy Balderson (OH-12) Rep. Diana Harshbarger (TN-01) Rep. Mariannette Miller-Meeks (IA-01) Rep. Kat Cammack (FL-03) Rep. Jay Obernolte (CA-23) Rep. John James (MI-10) Rep. Cliff Bentz (OR-02) Rep. Erin Houchin (IN-09) Rep. Nick Langworthy (NY-23) Rep. Tom Kean, Jr. (NJ-07)  Rep. Michael Rulli (OH-06) Rep. Brett Guthrie (KY-02), Ex-Officio Subcommittee on  Environment: Rep. Morgan Griffith (VA-09), Chairman Rep. Dan Crenshaw (TX-02), Vice Chairman Rep. Bob Latta (OH-05) Rep. Buddy Carter (GA-01) Rep. Gary Palmer (AL-06) Rep. John Joyce (PA-13) Rep. Randy Weber (TX-14) Rep. August Pfluger (TX-11) Rep. Mariannette Miller-Meeks (IA-01) Rep. Laurel Lee (FL-15) Rep. Nick Langworthy (NY-23) Rep. Gabe Evans (CO-08) Rep. Julie Fedorchak (ND-AL) Rep. Brett Guthrie (KY-02), Ex-Officio Subcommittee on  Oversight & Investigations: Rep. Gary Palmer (AL-06), Chairman Rep. Troy Balderson (OH-12), Vice Chairman Rep. Morgan Griffith (VA-09) Rep. Neal Dunn (FL-02) Rep. Dan Crenshaw (TX-02) Rep. Randy Weber (TX-14) Rep. Rick Allen (GA-12) Rep. Russ Fulcher (ID-01) Rep. Michael Rulli (OH-06) Rep. Brett Guthrie (KY-02), Ex-Officio Subcommittee on Commerce, Manufacturing, & Trade: Rep. Gus Bilirakis (FL-12), Chairman Rep. Russ Fulcher (ID-01), Vice Chairman Rep. Diana Harshbarger (TN-01) Rep. Kat Cammack (FL-03) Rep. Jay Obernolte (CA-23) Rep. John James (MI-10) Rep. Cliff Bentz (OR-02) Rep. Erin Houchin (IN-09) Rep. Russell Fry (SC-07) Rep. Laurel Lee (FL-15) Rep. Tom Kean, Jr. (NJ-07)  Rep. Gabe Evans (CO-08) Rep. Craig Goldman (TX-12)  Rep. Brett Guthrie (KY-02), Ex-Officio ###



Jan 6, 2025
Press Release

Chairman Guthrie Announces House Committee on Energy and Commerce Subcommittee Chief Counsels

WASHINGTON, D.C.  – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, announced the Committee’s Subcommittee Chief Counsels for the 119th Congress: Subcommittee on Communications and Technology  Chief Counsel - Kate Harper Kate O’Connor Harper will serve as Chief Counsel for the Subcommittee on Communications and Technology, where she has served for the past 5 years. Kate previously served as the Chief of Staff for the National Telecommunications and Information Administration, where she worked on legislative and communications policy focused on spectrum and broadband issues. She also worked in NTIA’s Office of Congressional Affairs and engaged with Congress, state government officials, and other federal agencies to advance the Administration’s legislative initiatives on broadband and 5G. Subcommittee on Commerce, Manufacturing, and Trade Chief Counsel - Giulia Leganski Giulia Leganski will serve as Chief Counsel for the Subcommittee on Commerce, Manufacturing, and Trade. Prior to this role, Giulia served as a Professional Staff Member for the Subcommittee on Communications and Technology, handling issues related to Big Tech, Section 230, Artificial Intelligence, cybersecurity, media, and public safety. Previously, Giulia worked as a Professional Staff Member for the House Small Business Committee, as Acting Deputy Assistant Secretary for Legislative Affairs at the U.S. Department of State, and in the White House Office of Legislative Affairs.  Subcommittee on Energy  Chief Counsel - Mary K. Martin Mary K. Martin will serve as Chief Counsel for the Subcommittee on Energy. Prior to her years at Energy and Commerce, Mary previously served as policy counsel and committee executive to the Environment, Technology & Regulatory Affairs Division at the U.S. Chamber of Commerce. Before joining the Chamber, Mary spent 10 years as an attorney in private practice litigating complex commercial disputes, including environmental contamination, toxic tort, breach of contract, and insurance coverage matters. Most recently, Mary served as Of Counsel at Steptoe & Johnson LLP in Washington, D.C.  Subcommittee on Environment  Chief Counsel - Jake Tyner  Jake Tyner will serve as Chief Counsel for the Subcommittee on Environment. Jake has extensive Capitol Hill experience, most recently serving as General Counsel for Senator Dan Sullivan. In this role, Jake led the Senator’s efforts on issues related to energy, then environment, natural resources, and permitting and regulatory reform. Prior to joining Senator Sullivan’s office, Jake worked for Congressman David McKinley of West Virginia, the ranking member on the Environment & Climate Change Subcommittee in the U.S. House of Representatives and at the U.S. Chamber of Commerce. Subcommittee on Health Chief Counsel - Jay Gulshen Jay Gulshen will serve as Chief Counsel for the Subcommittee on Health. Jay most recently served as a Senior Health Advisor for the Committee on Energy and Commerce, working on Medicare Part B and Part D. Prior to returning to Energy and Commerce, Jay worked for the Committee on Ways and Means, advising on Medicare Parts A and B, served as the Health Policy Advisor for Congressman Buddy Carter, and as a Legislative Associate for the Energy and Commerce’s Health Subcommittee. Subcommittee on Oversight & Investigations  Chief Counsel - Brittany Havens Brittany Havens will serve as Chief Counsel for the Subcommittee on Oversight and Investigations. Prior to this role, Brittany served as a Senior Oversight Counsel on the Committee on Ways and Means Oversight Subcommittee working on a variety of issues, including oversight of federal agencies and programs; oversight of the tax-exempt sector; and legislation related to matters of tax administration. Prior to that, Brittany served in various roles for the Committee on Energy and Commerce between 2012 - 2022, most recently as a Professional Staff Member, conducting oversight on a wide range of topics within the Committee’s jurisdiction. The House Committee on Energy and Commerce Subcommittee staff will work under the direction of Staff Director Megan Jackson, Deputy Staff Director Sophie Khanahmadi, and Chief Counsel Joel Miller.


Subcommittee Members

(18)

Chairman Oversight and Investigations

Gary Palmer

R

Alabama – District 6

Vice Chairman Oversight and Investigations

Troy Balderson

R

Ohio – District 12

Ranking Member Oversight and Investigations

Yvette Clarke

D

New York – District 9

Morgan Griffith

R

Virginia – District 9

Neal Dunn, M.D.

R

Florida – District 2

Dan Crenshaw

R

Texas – District 2

Randy Weber

R

Texas – District 14

Rick Allen

R

Georgia – District 12

Russ Fulcher

R

Idaho – District 1

Michael Rulli

R

Ohio – District 6

Brett Guthrie

R

Kentucky – District 2

Diana DeGette

D

Colorado – District 1

Paul Tonko

D

New York – District 20

Lori Trahan

D

Massachusetts – District 3

Lizzie Fletcher

D

Texas – District 7

Alexandria Ocasio-Cortez

D

New York – District 14

Kevin Mullin

D

California – District 15

Frank Pallone

D

New Jersey – District 6

Recent Letters


Dec 19, 2024
Press Release

E&C Republicans Request HHS Watchdog Investigate Promotion of Gender Transition Procedures for Children

Washington, D.C. — In a new letter to Department of Health and Human Services (HHS) Inspector General Christi Grimm, House Energy and Commerce Committee Republicans requested an investigation into the strength, quality, and types of evidence-based scientific and pediatric medical literature relied on by the department to promote gender transition procedures for children.  KEY LETTER EXCERPT:  “As the agency responsible for safeguarding the health and well-being of Americans, all of HHS’s medical treatment recommendations, especially medical treatment recommendations for children, should be based on rigorous and well-established research, such as randomized controlled trials, that have definitively illustrated the long-term benefits of gender affirming care treatments.”  BACKGROUND:  Under the Biden administration, HHS has advocated for sex reassignment procedures on minors, including the use of serum puberty blockers, which have historically been used to treat children with precocious puberty (i.e., early onset puberty affecting about one percent of U.S. children) and sex offenders.   Puberty blockers, however, are known to stunt normal childhood development in children unaffected by precocious puberty.  HHS officials contend that sex reassignment procedures on minors are an unanimously accepted medical practice.  HHS Secretary Becerra testified before Congress that “every major medical association,” “medical journals,” and “scientific and medical evidence” has demonstrated the benefits of transitioning children’s biological sex.  When asked, via a Freedom of Information Act request, for the underlying scientific or medical basis for its position, HHS was only able to produce a two-page brochure that was already publicly available.  In contrast to HHS, a growing body of literature from medical experts and authorities around the world, including those in Europe, caution against performing such procedures on minors.   Courts and government health agencies responsible for determining child welfare have sought to limit child sex reassignment procedures.   Other countries have banned these interventions and surgeries on minors altogether.  An article published in the British Journal of Medicine found “there is great uncertainty about the effects of puberty blockers, cross-sex hormones, and surgeries in young people.”   A court in the United Kingdom noted the obvious about administering puberty blocking chemicals onto children: “[i]t is highly unlikely that a child aged 13 or under would be competent to give consent to the administration of puberty blockers. It is doubtful that a child aged 14 or 15 could understand and weigh the long-term risks and consequences of the administration of puberty blockers.”  In April 2024, the Cass Review , an independent review of gender identity services for children and young people, commissioned by the National Health Service England, found “[w]hile a considerable amount of research has been published in this field, systematic evidence reviews demonstrated the poor quality of the published studies, meaning there is not a reliable evidence base upon which to make clinical decisions, or for children and their families to make informed choices.”   The Cass Review also found that “[t]he rationale for early puberty suppression remains unclear, with weak evidence regarding the impact on gender dysphoria, mental or psychosocial health,” as well as unknown effects on cognitive and psychosexual development.  In August 2024, the American Society of Plastic Surgeons (ASPS) became the first major U.S. medical association to express caution on the use of gender surgery for gender dysphoria in adolescents. In its formal statement, the association stated: “ASPS currently understands that there is considerable uncertainty as to the long-term efficacy for the use of chest and genital surgical interventions for the treatment of adolescents with gender dysphoria, and the existing evidence base is viewed as low quality/low certainty. This patient population requires specific considerations.”   The letter was signed by Committee Chair Cathy McMorris Rodgers (R-WA), Subcommittee on Health Chair Brett Guthrie (R-KY), Subcommittee on Oversight and Investigations Chair Morgan Griffith (R-VA), Rep. Dan Crenshaw (R-TX), Rep. Gus Bilirakis (R-FL), Rep. Buddy Carter (R-GA), Rep. Gary Palmer (R-AL), Rep. Neal Dunn (R-FL), Rep. Randy Weber (R-TX), Rep. Troy Balderson (R-OH), Rep. August Pfluger (R-TX), Rep. Diana Harshbarger (R-TN), and Rep. Kat Cammack (R-FL).  CLICK HERE to read the letter.



Nov 22, 2024
Press Release

E&C, E&W Republicans Press Gladstone Institutes for Information Regarding Internal Antisemitism

House Republicans scrutinize government grant funding recipients that fail to protect individuals from antisemitism Washington, D.C. — In a new letter to J. David Gladstone Institutes President Dr. Deepak Srivastava, the House Committee on Energy and Commerce (E&C) and House Committee on Education and the Workforce (E&W) have requested information about ongoing and pervasive acts of antisemitic harassment and intimidation at Gladstone and its leadership’s insufficient response to these acts. The letter is signed by E&C Chair Cathy McMorris Rodgers (R-WA), E&C Subcommittee on Health Chair Brett Guthrie (R-KY), E&C Oversight and Investigations Subcommittee Chair Morgan Griffith (R-VA), E&W Chair Virginia Foxx (R-NC), and E&W Subcommittee on Higher Education and Workforce Development Chair Burgess Owens (R-UT).  KEY LETTER EXCERPTS: “The Gladstone Institutes, an independent biomedical research organization, claims that it takes an active stance against serious issues like discrimination and harassment and aims to ‘ensure all community members at Gladstone feel included’ and that the Institutes will aim to ‘implement accountability measures and reinforce Gladstone’s commitment to having an environment free of harassment.’ However, these values do not seem to be reflected in the actions of leadership in response to recent concerns of antisemitic harassment and discrimination within the Institutes.” [...] “The reports of antisemitic harassment at Gladstone coupled with the inadequate response by leadership is concerning to the Committees. Failing to act decisively to ensure a safe environment for all trainees, faculty, and staff is a grave dereliction of your responsibilities as President of Gladstone.” “Failing to comply with basic safety protections for members of Gladstone or failure to respond appropriately to and prevent harassment and discrimination, no matter the cause, may be grounds to withhold federal funds from the university. Congress has an obligation to exercise oversight of recipients of federal funds when blatant and ongoing Title VI violations appear to be happening. If Congress determines an institution of higher education/research is blatantly ignoring its legal responsibilities, we may consider rescinding research and development funds previously appropriated.” BACKGROUND ON TAXPAYER FUNDING: Gladstone received more than $41 million in funding from the NIH in Fiscal Year 2023, not including potential taxpayer funding that individual faculty may have received through their affiliation with the University of California, San Francisco (UCSF) or any other affiliated universities.   According to the NIH’s Grant Policy Statement, any institution receiving federal funds must assure work environments are free of discriminatory harassment and are safe and conducive to high-quality work.  Institutions receiving federal taxpayer financial assistance—such as NIH grants—are prohibited from discriminating based on a variety of categories, including national origin.   These laws also protect members of the institution who are or are perceived to be members of a group with shared ancestry, such as students/trainees of Jewish heritage. BACKGROUND ON INSTANCES OF ANTISEMITISM : Two days after the October 7, 2023, Hamas terrorist attack, a graduate student working in a lab within Gladstone sent an antisemitic email to all Gladstone faculty, trainees, and staff falsely stating that the attack on innocent Israeli civilians was “the resistance in Gaza launch[ing] a surprise attack against Israel, taking occupation soldiers hostage, taking over Israeli military vehicles, and gain[ing] control over illegal Israeli settlements.”  The email goes on to claim that all casualties resulting from Palestinian actions are the responsibility of Israel.  Immediately following this mass email, members of the Gladstone faculty began contacting the Gladstone Institutes’ President and other leadership, appalled by the language of the email, concerned for their safety and worried that the email could be seen as an incitement to violence.  Jewish members of the Institutes also expressed their deep, personal pain following the Hamas attack, as some members had family or friends reported killed or missing directly after the attack.  These fears—including fears of being attacked in the lab by the author of this cruel and antagonistic email—were shared directly with President Srivastava.  Despite this, Gladstone leadership did not issue a public statement or position against antisemitism to quell fears of Jewish faculty and trainees.  In May 2024, the Center for Combatting Antisemitism sent President Srivastava a letter requesting administrative action to address the hostile environment and disparate treatment of Jewish members at Gladstone.  This letter noted that Gladstone refused to acknowledge Jewish American Heritage Month, Passover, or Holocaust Remembrance Day, despite sending official celebratory emails and holding events for other religious, ethnic, or national holidays, including Black History Month, International Women’s Day, and Ramadan.  The Center followed up with Gladstone several times, but never received a response.  Jewish faculty and trainees have conveyed to leadership within Gladstone instances of antisemitic harassment and discrimination, which faculty and trainees believe were not taken seriously, making some feel uneasy about speaking out.  For example, per a publicly available Fair Employment and Housing Act complaint to the California Civil Rights Division, a Jewish faculty member openly discussed fellow faculty using racial stereotypes, including comments about a “Jewish nose.”  When these comments were brought to human resources, no investigation occurred.  Instead, the complainant was subsequently targeted with an investigation ultimately deemed to be unwarranted.  Then, following the complainant’s post-October 7th advocacy on behalf of Jewish faculty and trainees, the complainant was threatened repeatedly with career-ending termination, allegedly in an attempt to extort a resignation.  When the threats did not have their desired effect, Gladstone placed the complainant on administrative leave and removed the complainant’s electronic access to email and files but also physical access to the complainant’s lab, removing all ability to conduct work on an NIH-funded grant.  Gladstone ultimately paid an undisclosed sum to settle the matter and avoid litigation.  To elevate concerns regarding widespread, ongoing discrimination, Jewish faculty and trainees requested permission to bring in a speaker related to antisemitism.  Other minority groups had previously been given permission to bring in similar anti-racism speakers.  However, while leadership stated it would look into the idea, ultimately no speaker was brought, and no program was launched regarding antisemitism. BACKGROUND ON AFFILIATIONS WITH OTHER INSTITUTIONS UNDER INVESTIGATION : Gladstone Institutes is affiliated with other institutions under congressional investigation.  For example, Gladstone is an affiliate of the UCSF, which is undergoing congressional investigation for reports of antisemitism within the university, medical school, and medical centers.  Most of Gladstone’s principal investigators are also faculty at UCSF, and the Institutes provide research positions and opportunities for graduate students from UCSF.  Moreover, there is a joint institute—the Gladstone-UCSF Institute of Genomic Immunology—further linking the two institutions.  Gladstone is also affiliated with the University of California, Berkeley and Stanford University, both of which are also under investigation for concerns related to antisemitism. CLICK HERE to read the full letter.



Nov 12, 2024
Press Release

E&C Republicans Ask GAO to Assess Structure of CDC, FDA, and NIH Lab Safety Offices

Washington, D.C. — In a new letter to Government Accountability Office Comptroller General Gene Dodaro, House Energy and Commerce Committee Republicans have requested an examination of the structure of laboratory safety programs at the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), and the National Institutes of Health (NIH).  The letter was signed by Committee Chair Cathy McMorris Rodgers (R-WA), Subcommittee on Health Chair Brett Guthrie (R-KY), and Subcommittee on Oversight and Investigations Chair Morgan Griffith (R-VA).  KEY LETTER EXCERPT :  This committee remains concerned about the effectiveness of the oversight HHS and its agencies provide to the laboratories they own and operate. In addition to numerous GAO recommendations that remain unimplemented by the FDA, both the CDC and the FDA recently announced organizational reforms to their laboratory safety and security functions, and it is not clear whether these changes will strengthen oversight or create new undue risk. The FDA has, for example, reorganized several of its laboratories such that they now fall within the Office of the Chief Scientist. This raises potential independence concerns, as the FDA’s laboratory safety and security functions report to the same office.  BACKGROUND :  The mission of the U.S. Department of Health and Human Services (HHS) is to enhance the health and well-being of all Americans.   As such, HHS is most directly involved in leading public health preparedness and response efforts, as well as associated research.   However, past safety lapses involving the CDC, the FDA, and the NIH have been the result of multiple breakdowns in compliance with established policies coupled with inadequate oversight.   For example, in July 2014, boxes containing decades-old vials of smallpox and other hazardous biological agents were found in a storage space of an FDA laboratory on the NIH’s campus. GAO and other reviews resulted in numerous findings and recommendations to strengthen laboratory safety and security, which led to changes to the way HHS and its agencies oversee their laboratories.   Likewise, GAO and other reviews have highlighted the importance of laboratory science and security in the handling of federal select agents and other dangerous pathogens in research.  CLICK HERE to read the full letter.